文献速递心力衰竭与心肌病心律失常

收缩性心衰患者全天中枢性呼吸暂停的预后意义

Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure.
PubMed 文献 · J Am Coll Cardiol · 2017-01-01

本研究前瞻性纳入525例接受指南推荐治疗的收缩性心衰患者,进行24小时呼吸记录并随访心脏死亡终点。结果显示24小时中枢性呼吸暂停患病率64.8%,夜间、日间及24小时中重度中枢性呼吸暂停均与心脏死亡率增加相关,且年龄、BNP、肾功能、24小时AHI、CAI及血氧饱和度低于90%时间为独立预测因素。

要点

  • 收缩性心衰患者中枢性呼吸暂停全天均可出现,24小时患病率64.8%。
  • 日间及夜间中重度中枢性呼吸暂停均与心脏死亡风险增加相关。
  • 24小时呼吸监测有助于识别心衰患者的中枢性呼吸暂停及高危风险。

核心结论

  • 收缩性心衰患者中枢性呼吸暂停贯穿24小时,并与神经激素激活、室性心律失常负荷及更差预后相关。

研究设计与样本

  • 前瞻性队列研究,连续纳入525例接受指南推荐治疗的收缩性心衰患者,进行24小时呼吸记录并随访心脏死亡终点。

主要发现

  • 24小时以中枢性呼吸暂停为主的患病率为64.8%,夜间为69.1%,日间为57.0%。
  • 中位随访34个月(IQR 17-36个月)期间发生50例心脏死亡。
  • 夜间、日间及24小时中重度中枢性呼吸暂停均与心脏死亡率增加相关(AHI≥15次/小时 log-rank分别为6.6、8.7、5.3,均p<0.05;CAI≥10次/小时 log-rank分别为8.9、11.2、10.9,均p<0.001)。
  • 年龄、B型利钠肽水平、肾功能不全、24小时AHI、CAI及血氧饱和度低于90%的时间是预后的独立预测因素。

关键数值与推荐

  • 以中枢性呼吸暂停为主定义为AHI≥5次/小时且中枢性呼吸暂停占比>50%。
  • 以阻塞性呼吸暂停为主定义为AHI≥5次/小时且阻塞性呼吸暂停占比>50%。
  • 中重度中枢性呼吸暂停分别以AHI≥15次/小时和CAI≥10次/小时为界值。

临床怎么用

  • 对收缩性心衰患者可考虑进行24小时呼吸监测以评估中枢性呼吸暂停及其全天分布。
  • 识别合并中重度中枢性呼吸暂停的心衰患者有助于风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Large trials using noninvasive mechanical ventilation to treat central apnea (CA) occurring at night ("sleep apnea") in patients with systolic heart failure (HF) have failed to improve prognosis. The prevalence and prognostic value of CA during daytime and over an entire 24-h period are not well described. OBJECTIVES: This study evaluated the occurrence and prognostic significance of nighttime, daytime, and 24-h CA episodes in a large cohort of patients with systolic HF. METHODS: Consecutive patients receiving guideline-recommended treatment for HF (n = 525; left ventricular ejection fraction [LVEF] of 33 ± 9%; 66 ± 12 years of age; 77% males) underwent prospective evaluation, including 24-h respiratory recording, and were followed-up using cardiac mortality as an endpoint. RESULTS: The 24-h prevalence of predominant CAs (apnea/hypopnea index [AHI] ≥5 events/h, with CA of >50%) was 64.8% (nighttime: 69.1%; daytime: 57.0%), whereas the prevalence of predominant obstructive apneas (OA) was 12.8% (AHI ≥5 events/h with OAs >50%; nighttime: 14.7%; daytime: 5.9%). Episodes of CA were associated with neurohormonal activation, ventricular arrhythmic burden, and systolic/diastolic dysfunction (all p < 0.05). During a median 34-month follow-up (interquartile range [IQR]: 17 to 36 months), 50 cardiac deaths occurred. Nighttime, daytime, and 24-h moderate-to-severe CAs were associated with increased cardiac mortality (AHI of </≥15 events/h; log-rank: 6.6, 8.7, and 5.3, respectively; all p < 0.05; central apnea index [CAI] of </≥10 events/h; log-rank 8.9, 11.2, and 10.9, respectively; all p < 0.001). Age, B-type natriuretic peptide level, renal dysfunction, 24-h AHI, CAI, and time with oxygen saturation of <90% were independent predictors of outcome. CONCLUSIONS: In systolic HF patients, CAs occurred throughout a 24-h period and were associated with a neurohormonal activation, ventricular arrhythmic burden, and worse prognosis.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Emdin M, Mirizzi G, Giannoni A, et al. Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure. J Am Coll Cardiol. 2017. PMID: 28882233. doi:10.1016/j.jacc.2017.07.740

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。